Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 6, 2003, Pages 1319-1327

  Erpenbeck, Veit J ^a,b   Hohlfeld, Jens M ^a   Volkmann, Brunhild ^a   Hagenberg, Andreas ^a   Geldmacher, Henning ^a   Braun, Armin ^a   Krug, Norbert ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Asthma; Atopy; IL 9; Real time PCR; Segmental allergen challenge

Indexed keywords

ALLERGEN; INTERLEUKIN 9; MESSENGER RNA; PROTEIN;

ADULT; ALLERGIC ASTHMA; ARTICLE; CELL ASSAY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG LAVAGE; LYMPHOCYTE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROVOCATION TEST; RNA ANALYSIS; TIME;

EID: 0038518063     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1485     Document Type: Article

References (27)

1. Modi WS, Pollock DD, Mock BA, Banner C, Renauld JC, Van Snick J. Regional localization of the human glutaminase (GLS) and interleukin-9 (IL9) genes by in situ hybridization. Cytogenet Cell Genet 1991;57:114-6.
2. Uyttenhove C, Simpson RJ, Van Snick J. Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci U S A 1988;85:6934-8.
3. Hultner L, Druez C, Moeller J, Uyttenhove C, Schmitt E, Rude E, et al. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGF (interleukin 9). Eur J Immunol 1990;20:1413-6.
4. Dugas B, Renauld JC, Pene J, Bonnefoy JY, Peti-Frere C, Braquet P, et al. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 1993;23:1687-92.
5. Louahed J, Zhou Y, Maloy WL, Rani PU, Weiss C, Tomer Y, et al. Interleukin 9 promotes influx and local maturation of eosinophils. Blood 2001;97:1035-42.
6. Gounni AS, Gregory B, Nutku E, Aris F, Latifa K, Minshall E, et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation and survival of human eosinophils. Blood 2000;96:2163-71.
7. Dong Q, Louahed J, Vink A, Sullivan CD, Messler CJ, Zhou Y, et al. IL-9 induces chemokine expression in lung epithelial cells and base airway eosinophilia in transgenic mice. Eur J Immunol 1999;29:2130-9.
8. Little FF, Cruikshank WW, Center DM, Il-9 stimulates release of chemotactic factors from human bronchial epithelial cells. Am J Respir Cell Mol Biol 2001;25:347-52.
9. Temann UA, Geba GP, Rankin JA, Flavell RA. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998;188:1307-20.
10. Temann UA, Ray P, Flavell RA. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest 2002;109:29-39.
11. Levitt RC, McLane MP, MacDonald D, Ferrante V, Weiss C, Zhou T, et al. IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol 1999;103(suppl):S485-91.
12. Kung TT, Luo B, Crawley Y, Garlisi CG, Devito K, Minnicozzi M, et al. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am J Respir Cell Mol Biol 2001;25:600-5.
13. Cheng G, Arima M, Honda K, Hirata H, Eda F, Yoshida N, et al. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med 2002;166:409-16.
14. McMillan SJ, Bishop B, Townsend MJ, McKenzie AN, Lloyd CM. The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J Exp Med 2002;195:51-7.
15. Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC, et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 2000;105:108-15.
16. Ying S, Meng Q, Kay AB, Robinson DS. Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin Exp Allergy 2002;32:866-71.
17. Jenmalm MC, Van Snick J, Cormont F, Salman B. Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children. Clin Exp Allergy 2001;31:1528-35.
18. International Consensus Report on Diagnosis and Treatment of Asthma. Clin Exp Allergy 1992;22(suppl 1):1-72.
19. Krug N, Erpenbeck VJ, Balke K, Petschallies J, Tschemig T, Hohlfeld JM, et al. Cytokine profile of bronchoalveolar lavage-derived CD4(+), CD8(+), and gammadelta T cells in people with asthma after segmental allergen challenge. Am J Respir Cell Mol Biol 2001;25:125-31.
20. Bhathena PR, Comhair SA, Holroyd KJ, Erzurum SC. Interleukin-9 receptor expression in asthmatic airways In vivo. Lung 2000;178:149-60.
21. Houssiau FA, Renauld JC, Fibbe WE, Van Snick J. IL-2 dependence of IL-9 expression in human T lymphocytes. J Immunol 1992;148:3147-51.
22. Renauld JC, Houssiau F, Uyttenhove C, Vink A, Van Snick J, Interleukin-9: a T-cell growth factor with a potential oncogenic activity. Cancer Invest 1993:11:635-40.
23. Schmitt E, Germann T, Goedert S, Hoehn P, Huels C, Koelsch S, et al. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol 1994;153:3989-96.
24. Gounni AS, Nutku E, Koussih L, Aris F, Louahed J, Levitt RC, et al. IL-9 expression by human eosinophils: regulation by IL-1beta and TNF-alpha. J Allergy Clin Immunol 2000;106:460-6.
25. Sedgwick JB, Shikama Y. Nagata M, Brener K, Busse WW. Effect of isolation protocol on eosinophil function: Percoll gradients versus immunomagnetic beads. J Immunol Methods 1996;198:15-24.
26. Toda M, Tulic MK, Levitt RC, Hamid Q. A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients asthma. J Allergy Clin Immunol 2002;109:246-50.
27. O'Brien PJ, Louahed J, Zhou Y, Dang Q, Weiss C, Renauld JC, et al. IL-9 directly regulates IL-13 expression in vitro, and in vivo [abstract]. Am J Respir Crit Care Med 2002;165:A202.